Sanofi Consumer Healthcare India has reported results for fourth quarter (Q4) and the year ended December 31, 2025.
The company has reported 50.11% jump in its net profit at Rs 66.50 crore for the quarter ended December 31, 2025 as compared to Rs 44.30 crore for the same quarter in the previous year. The total income of the company increased by 45.48% at Rs 255.60 crore for December quarter as compared to Rs 175.70 crore for the corresponding quarter previous year.
For the year ended December 31, 2025, the company has reported 32.65% rise in its net profit at Rs 240.10 crore as compared to Rs 181.00 crore for the previous year. The total income of the company increased by 21.60% at Rs 896.80 crore for the year ended December 31, 2025 as compared to Rs 737.50 crore for year ended December 31, 2024.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.40 |
| Dr. Reddys Lab | 1282.15 |
| Cipla | 1304.70 |
| Zydus Lifesciences | 956.65 |
| Lupin | 2249.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: